3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
4
Breast Neoplasms
4
Liver Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Carcinoma, Non-Small-Cell Lung
2
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pain
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Melanoma
1
Malignant Pleural Neoplasm
1
Lung Neoplasms
1
Localised Prostate Cancer
1
Leiomyoma
1
Ileus
1
Hordeolum
1
Glioblastoma
1
Eyelid Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Lidocaine
×
1 year
×
Clear all
No trials found.